Table IV.
Fifteen most used pharmacological subclasses and common chronic health problems
| INFARMED pharmacotherapeutic classification | % (n) | ICPC-2 chronic health problems | % (n) | ||
|---|---|---|---|---|---|
| 3.4.2 | ACE inhibitor/ARBs | 56.8 (430) | K86 | Hypertension uncomplicated | 54.7 (414) |
| 3.7.1 | Statins | 52.0 (394) | T93 | Lipid disorder | 48.1 (364) |
| 2.10 | Analgesics and antipyretics | 50.6 (383) | T90 | Diabetes non-insulin dependent | 24.0 (182) |
| 6.2.2.3 | PPIs | 38.2 (289) | L86 | Back syndrome with radiating pain | 17.7 (134) |
| 3.4.1.1 | Thiazide | 37.5 (284) | L90 | Osteoarthrosis of knee | 16.2 (123) |
| 2.9.1.3 | Benzodiazepines | 33.6 (254) | T82 | Obesity | 14.8 (112) |
| 3.4.3 | Calcium channel blockers | 26.7 (202) | K87 | Hypertension complicated | 14.1 (107) |
| 2.9.3 | Antidepressants | 24.7 (187) | P76 | Depressive disorder | 13.2 (100) |
| 4.3.1.3 | Antiplatelet agents | 23.6 (179) | Y85 | Benign prostatic hypertrophy | 12.9 (98) |
| 9.1.3 | NSAIDs – propionic acid derivatives | 22.3 (169) | T83 | Overweight | 12.2 (92) |
| 3.4.4.2 | β-Blockers | 21.9 (166) | L91 | Osteoarthrosis other | 10.8 (82) |
| 8.4.2.1 | Biguanide | 21.4 (162) | K95 | Varicose veins of leg | 10.0 (76) |
| 8.2 | Corticosteroids | 18.1 (137) | F92 | Cataract | 9.4 (71) |
| 10.1.2 | H1 non-sedative antihistamines | 17.7 (134) | P74 | Anxiety disorder/anxiety state | 9.4 (71) |
| 2.12 | Narcotic analgesics | 15.3 (116) | L87 | Bursitis/tendinitis/synovitis NOS | 8.6 (65) |